Oxford's HIV vaccine starts Phase 1 clinical trials in the UK
|
A
novel HIV vaccine, developed at the University of Oxford in the wake of
Covid-19 vaccine success, is to be trialled on humans. The goal of the
trial, ... |
Johnson & Johnson HIV vaccine fails in clinical trial
A HIV vaccine candidate trialled in Sub-Saharan Africa has failed to demonstrate any substantial protection against HIV infection in young women. View article...
